Zinta Krumins, the newly-appointed managing director of Boehringer Ingelheim UK and Ireland, has warned that the ‘devil is in the …

The government has launched a consultation which aims to establish whether doctors are being held back from using innovative treatments, …

The UK managing director of Pfizer Jonathan Emms is to replace Deepak Khanna as the ABPI president from April next …

The Ethical Medicines Industry Group (EMIG) has slammed the new PPRS plan, calling it a ‘dreadful deal’ for its members. …

The fallout from last week’s new drug pricing plan in the UK is continuing as nine pharma firms write an …

A missed opportunity for patients, which creates financial problems for smaller companies while stifling life science investment – these are …

The UK government has announced that the PPRS pricing scheme will largely remain intact, but will have a curb put …
An official review of primary care prescribing in Scotland has welcomed savings made, but says further efficiencies are possible.Audit Scotland …
An influential group of MPs has hit out at inactivity over moves towards value-based pricing (VBP), saying that the issue …

The ABPI has set out what it wants to see from the new drug pricing system in the UK. Negotiations …

The ABPI has attacked the UK government’s new drug pricing policy, saying it will not benefit the pharma industry. Value-Based …

As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …

The UK pharmaceutical industry says too great a focus on ‘breakthrough’ drugs could undermine the future of medical research in …
Plans to revolutionise the pricing of medicines in the UK look to be another casualty in the Department of Health’s …